We are live on ! Find out more
TCP

Tourbillon Capital Partners Portfolio holdings

AUM $6.26M
1-Year Est. Return 42.29%
This Fund
S&P 500
This Quarter Est. Return
+10.87%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
AUM
$3.71B
AUM Growth
+$963M
Cap. Flow
+$908M
Cap. Flow %
24.49%
Top 10 Hldgs %
38.05%
Holding
132
New
49
Increased
24
Reduced
12
Closed
44

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$105M
2
AMZN icon
Amazon
AMZN
+$62.3M
3
AVGO icon
Broadcom
AVGO
+$57.6M
4
TSN icon
Tyson Foods
TSN
+$56.8M
5
MDVN
MEDIVATION, INC.
MDVN
+$52M

Sector Composition

Rank Sector Weight
1 Healthcare 12.26%
2 Consumer Discretionary 9.59%
3 Technology 6.55%
4 Consumer Staples 5.53%
5 Communication Services 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCPT
126
CALL
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
-110,000
Closed -$6.83M
GTAT
127
PUT
DELISTED
GT ADVANCED TECHNOLOGIES INC COM STK (DE)
GTAT
-1,990,000
Closed -$21.6M
SHPG
128
CALL
DELISTED
Shire pic
SHPG
-102,800
Closed -$26.6M
ACAS
129
DELISTED
American Capital Ltd
ACAS
-1,000,000
Closed -$14.2M
AGN
130
CALL
DELISTED
Allergan Inc
AGN
-100,000
Closed -$17.8M
CZR
131
CALL
DELISTED
Caesars Entertainment Corporation
CZR
-600,000
Closed -$7.55M
CZR
132
DELISTED
Caesars Entertainment Corporation
CZR
-1,450,000
Closed -$18.2M

Similar funds

Tourbillon Capital Partners's Q4 2014 Portfolio in Review

As of Q4 2014, Tourbillon Capital Partners held 132 positions worth $3.71B, up 35% from $2.74B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tourbillon Capital Partners deployed $908M of net new capital in Q4 2014, opening 49 new positions and adding to 24 existing holdings. Its largest new stake was Bausch Health: 780,000 shares worth $112M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was AMAG Pharmaceuticals, an estimated $15M trimmed.

  • Tourbillon Capital Partners's largest Q4 2014 buy was Bausch Health: 780,000 shares worth $112M.
  • Tourbillon Capital Partners added most to Tyson Foods in Q4 2014, an estimated $56.8M increase.
  • Tourbillon Capital Partners's biggest Q4 2014 reduction was AMAG Pharmaceuticals, cutting an estimated $15M.
  • Tourbillon Capital Partners fully exited NXP Semiconductors in Q4 2014, selling an estimated $61.6M.
  • Tourbillon Capital Partners's ten largest holdings make up 38% of its $3.71B portfolio in Q4 2014.
  • Tourbillon Capital Partners opened 49 new positions and closed 44 in Q4 2014.
  • Tourbillon Capital Partners's portfolio value rose 35% quarter-over-quarter to $3.71B.

Based on Tourbillon Capital Partners's 13F filing for Q4 2014, filed 17 Feb 2015.